MDxHealth Acquires NovioGendix to Expand Uro-Oncology Product Offering
Go back to MDxHealth Acquires NovioGendix to Expand Uro-Oncology Product Offering| (NASDAQ: MDXH) | Delayed: 0.74 +0.02 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.72 | 52 Week High | $ | |||
| Open | $0.72 | 52 Week Low | $ | |||
| Day High | $0.75 | P/E | N/A | |||
| Day Low | $0.71 | EPS | $ | |||
| Volume | 396,459 | |||||

